Cargando…
Cardiotoxicity of Non-Anthracycline Cancer Chemotherapy Agents
Throughout the last decades, newly developed chemotherapeutic agents and immunotherapies that target signaling pathways have provided patients with better prognoses, improved their quality of life and increased survival rates, thus converting cancer to a stable chronic disease. However, non-anthracy...
| Autores principales: | , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
MDPI
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8953347/ https://www.ncbi.nlm.nih.gov/pubmed/35323614 http://dx.doi.org/10.3390/jcdd9030066 |